Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Next Generation Sequencing Asia 2016: Clinical Applications

Joe Daniel's Biography



Joe Daniel, Oncology Leader - Asia Pacific and Japan, Thermo Fisher Scientific

Joe Daniel started his career as a cancer researcher at the Royal Prince Alfred Hospital and the Garvan Institute of Medical Research in Sydney for 8 years. His projects related to elucidating the molecular mechanisms of lung and colorectal carcinogenesis with publications in journals such as Cancer Research, Journal of Clinical Oncology and Gut. From 2006 Joe transitioned into business development and account management roles first at Roche Diagnostics Australia and then at Life Technologies, now part of Thermo Fisher Scientific. In 2015 Joe moved to Singapore and is now responsible for Oncology business development and support in the Asia Pacific and Japan region for Thermo Fisher Scientific. He is passionate about improving cancer patient outcomes by enabling clinical labs with next generation molecular technologies.

Joe Daniel Image

Pioneering the Path Toward Precision Oncology Through Next-Generation Sequencing

Thursday, 1 December 2016 at 11:45

Add to Calendar ▼2016-12-01 11:45:002016-12-01 12:45:00Europe/LondonPioneering the Path Toward Precision Oncology Through Next-Generation SequencingNext Generation Sequencing Asia 2016: Clinical Applications in Taipei, TaiwanTaipei, TaiwanSELECTBIOenquiries@selectbiosciences.com

We will discuss the design elements and rationale of our Oncomine® Assay product line in the following applications:

  • Solid tumor assays for detection of SNVs, indels, CNVs, and gene fusions in a single workflow
  • Liquid biopsy assays for cfDNA and CTC analysis
  • Immune response assays


Add to Calendar ▼2016-12-01 00:00:002016-12-02 00:00:00Europe/LondonNext Generation Sequencing Asia 2016: Clinical ApplicationsNext Generation Sequencing Asia 2016: Clinical Applications in Taipei, TaiwanTaipei, TaiwanSELECTBIOenquiries@selectbiosciences.com